[Treatment of ulcus cruris. Clinical experiences using the Ulcrux cream and powder].
In an open trial 102 ulcera cruris of chronic venous genesis were treated locally with both Ulcrux Powder and Ointment in 54 female and 48 male patients over a period of 30 days. A positive result was obtained as to the shrinking of the wound area, the diminution of the substance defect, the development of granulations and the tendency towards epithelialisation. The influence on the cleansing of the wounds and on traumatic pain was also very favourable. Due to the rapid cleaning of the ulcera from necrotic films and to the good healing up tendency the therapeutic result was considered good to excellent with 81 patients (79,4%). Local side effects did not occur; the compatibility was also considered good in all cases. These test results prove that the combined treatment of chronic venous ulcera cruris with Ulcrux Ointment and Powder has real therapeutic advantages and seems to be superior to the traditional local forms of treatment.
D000085:Acetates / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000481:Allantoin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010205:Pantothenic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011208:Powders; D013752:Tetracycline / Q000627:therapeutic use*
D000085:Acetates; D004338:Drug Combinations; D009824:Ointments; D011208:Powders; D010205:Pantothenic Acid; D000481:Allantoin; D011092:Polyethylene Glycols; C013326:Ulcrux powder; C013325:Ulcrux; D006493:Heparin; D013752:Tetracycline
Zur Behandlung des Ulcus cruris Klinische Erfahrungen mit Ulcrux-Creme und -Puder